ABBV

|

AbbVie Inc

NYSE

USD 184.85
-0.86|-0.46%

Current Price

USD 184.85

Change

USD -0.86 (-0.46%)

P/E Ratio

78.64

Dividend Yield

3.56%

Market Cap

325.05B

Volume

5.50M

Open

USD 184.86

Previous Close

USD 185.71

52-Week High

USD 216.66

52-Week Low

USD 148.19

About AbbVie Inc
AbbVie Inc logo

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for...

Sector:Healthcare
Industry:Drug Manufacturers - General
CEO:Mr. Robert A. Michael CPA
Employees:55,000
Headquarters:North Chicago, USA
Website:www.abbvie.com

Track ABBV and More with ZuneMoney

Get real-time updates, portfolio tracking, and dividend forecasts.

Dividend History
Dividend Payments
Declared DateRecord DatePayment DateAmountFrequency
Feb 13, 2025Apr 15, 2025May 15, 2025USD 1.64
Oct 30, 2024Jan 15, 2025Feb 14, 2025USD 1.64
Sep 6, 2024Oct 15, 2024Nov 15, 2024USD 1.55
Jun 20, 2024Jul 15, 2024Aug 15, 2024USD 1.55
Feb 15, 2024Apr 15, 2024May 15, 2024USD 1.55
Oct 27, 2023Jan 16, 2024Feb 15, 2024USD 1.55
Sep 8, 2023Oct 13, 2023Nov 15, 2023USD 1.48
Jun 22, 2023Jul 14, 2023Aug 15, 2023USD 1.48
Feb 16, 2023Apr 14, 2023May 15, 2023USD 1.48
Oct 28, 2022Jan 13, 2023Feb 15, 2023USD 1.48
Sep 9, 2022Oct 14, 2022Nov 15, 2022USD 1.41
Jun 23, 2022Jul 15, 2022Aug 15, 2022USD 1.41
Feb 17, 2022Apr 15, 2022May 16, 2022USD 1.41
Oct 29, 2021Jan 14, 2022Feb 15, 2022USD 1.41
Sep 10, 2021Oct 15, 2021Nov 15, 2021USD 1.30
Jun 17, 2021Jul 15, 2021Aug 16, 2021USD 1.30
Feb 18, 2021Apr 15, 2021May 14, 2021USD 1.30
Oct 30, 2020Jan 15, 2021Feb 16, 2021USD 1.30
Sep 11, 2020Oct 15, 2020Nov 16, 2020USD 1.18
Jun 17, 2020Jul 15, 2020Aug 14, 2020USD 1.18
Feb 20, 2020Apr 15, 2020May 15, 2020USD 1.18
Nov 1, 2019Jan 15, 2020Feb 14, 2020USD 1.18
Sep 6, 2019Oct 15, 2019Nov 15, 2019USD 1.07
Jun 20, 2019Jul 15, 2019Aug 15, 2019USD 1.07
Feb 21, 2019Apr 15, 2019May 15, 2019USD 1.07
Nov 2, 2018Jan 15, 2019Feb 15, 2019USD 1.07
Sep 7, 2018Oct 15, 2018Nov 15, 2018USD 0.96
Jun 14, 2018Jul 13, 2018Aug 15, 2018USD 0.96
Feb 15, 2018Apr 13, 2018May 15, 2018USD 0.96
Oct 27, 2017Jan 12, 2018Feb 15, 2018USD 0.71
Sep 8, 2017Oct 13, 2017Nov 15, 2017USD 0.64
Aug 17, 2017Jul 11, 2017Aug 15, 2017USD 0.64
Feb 16, 2017Apr 13, 2017May 15, 2017USD 0.64
Oct 28, 2016Jan 13, 2017Feb 15, 2017USD 0.64
Sep 9, 2016Oct 14, 2016Nov 15, 2016USD 0.57
Jun 16, 2016Jul 15, 2016Aug 15, 2016USD 0.57
Feb 18, 2016Apr 15, 2016May 16, 2016USD 0.57
Oct 30, 2015Jan 15, 2016Feb 16, 2016USD 0.57
Similar Companies
Pfizer Inc. logo

Pfizer Inc.

PFE • NEW YORK STOCK EXCHANGE INC.

CEO:
Employees:83000
Location:Palo Alto, US
Bristol-Myers Squibb Co. logo

Bristol-Myers Squibb Co.

BMY • NEW YORK STOCK EXCHANGE INC.

CEO:Giovanni Caforio
Employees:34300
Location:New York, US
Lilly(Eli) & Co logo

Lilly(Eli) & Co

LLY • NEW YORK STOCK EXCHANGE INC.

CEO:David Ricks
Employees:39000
Location:Indianapolis, US
AMGEN Inc. logo

AMGEN Inc.

AMGN • NASDAQ

CEO:Robert Bradway
Employees:24300
Location:Thousand Oaks, US
Gilead Sciences, Inc. logo

Gilead Sciences, Inc.

GILD • NASDAQ

CEO:Daniel O'Day
Employees:17000
Location:Foster City, US
Biogen Inc logo

Biogen Inc

BIIB • NASDAQ

CEO:George Scangos
Employees:9100
Location:Cambridge, US
Astrazeneca plc logo

Astrazeneca plc

AZN • NASDAQ

CEO:Pascal Soriot
Employees:76100
Location:Cambridge, United Kingdom
Explore Stocks by Sector
Frequently Asked Questions

Track ABBV and More with ZuneMoney

Get real-time updates, portfolio tracking, and dividend forecasts.